• Yinglu Liu, Chunfu Wu, Zongjuan Hou, Xiaoxiao Fu, Linlin Yuan, Shibo Sun, Haotian Zhang, Depeng Yang, Xuechun Yao, and Jingyu Yang.
• Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, PR China.
• Neuroscience. 2020 Feb 1; 426: 33-49.

AbstractAfter ischemic stroke, the degenerated myelin caused by ischemic injury cannot be rapidly cleared away by microglia and interferes with the recovery process. Complement receptor 3 (CR3, CD11b/CD18), belonging to β2 integrin family primarily expressed in phagocytes, is involved in the microglial phagocytosis of myelin debris. We previously found that pseudoginsenoside-F11 (PF11), an ocotillol-type saponin, exerts neuroprotective effects against ischemic stroke and neuroinflammation. In the present study, we investigated the promotion of PF11 on oxygen-glucose deprivation (OGD)-induced microglial phagocytosis of myelin debris, the neuroprotection of PF11 on permanent middle cerebral artery occlusion (pMCAO)-induced ischemic stroke, and the possible role of CR3. The results indicated that PF11 (50 μM) accelerated the OGD-induced promotion of myelin debris phagocytosis by microglia in the early stage of OGD (2 h, 4 h, 8 h), which was significantly inhibited by anti-CD11b mAb or down-regulated by CD11b-specific siRNA. Meanwhile, PF11 strengthened the OGD-activated RhoA/ROCK signaling associated with the internalization during myelin debris phagocytosis through CR3. Consistently, the anti-CD11b mAb could markedly attenuated the nrueoprotective effects of PF11 (12 mg/kg, i.v.) on infarction and brain edema, neurological functions and loss of neurons of pMCAO rats. These findings suggest that PF11 accelerates the phagocytosis of myelin debris by microglia mainly through CR3, which may likely contribute to its neuroprotection against ischemic stroke.Copyright © 2019 IBRO. Published by Elsevier Ltd. All rights reserved.

25 keywords...

hide…